minoxidil has been researched along with Body Weight in 33 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the present study, we evaluated the effects of blockade of the RAS by the angiotensin-converting enzyme inhibitor enalapril and the angiotensin II receptor blocker losartan on left ventricular (LV) and right ventricular mass and LV dilation in relation to changes in central hemodynamics during the maintenance of minoxidil and aortocaval shunt-induced cardiac hypertrophy." | 7.69 | Effects of enalapril versus losartan on regression of volume overload-induced cardiac hypertrophy in rats. ( Leenen, FH; Ruzicka, M; Yuan, B, 1994) |
| "The antihypertensive and tissue-protective effects of nitrendipine were studied after long-term treatment of rats with experimental hypertension." | 7.68 | Long-term protective effects of nitrendipine in experimental hypertension. ( Kazda, S; Knorr, A; Neuser, D; Seuter, F; Stasch, JP, 1991) |
| "Five patients presenting with severe hypertension who failed to exhibit diastolic blood pressures less than 120 mm Hg following the oral administration of propranolol (60--80 mg) and furosemide (40 mg) received minoxidil (20 mg, p." | 7.66 | Rapid reduction of severe hypertension with minoxidil. ( Alpert, MA; Bauer, JH, 1980) |
| "The hemodynamic response to minoxidil, an orally active, potent vasodilator, was evaluated in 11 patients with severe chronic congestive heart failure (CHF)." | 7.66 | Minoxidil therapy in chronic congestive heart failure: acute plus long-term hemodynamic and clinical study. ( Chatterjee, K; Holly, AN; McKay, CR; Parmley, WW; Ports, TA, 1982) |
| "The efficacy and side effects of two potent vasodilatators, namely diazoxide and minoxidil given orally, were compared in 11 patients who had hypertension refractory to conventional drug treatment." | 7.66 | [Comparison of oral diazoxide and minoxidil in refractory hypertension]. ( Glück, Z; Grimm, M; Keusch, G; Meier, A; Minder, I; Reubi, FC; Weidmann, P, 1980) |
| "The mechanism of minoxidil-induced cardiac hypertrophy and its consequences for the myocardium have not been determined." | 5.29 | Structural and functional consequences of minoxidil-induced cardiac hypertrophy. ( Cifani, JR; Khairallah, PA; Milovanovic, M; Moravec, CS; Ruhe, T, 1994) |
| "Minoxidil treatment lowered blood pressure from 178/112 +/- 8/5 mm Hg (means +/- SEM) to 14/95 +/- 6/3 mm Hg." | 5.26 | Treatment of drug-resistant hypertension with minoxidil or angiotensin-converting enzyme inhibitor: blood pressure, renin, aldosterone, and electrolyte responses. ( Baer, L; Radichevich, I; Williams, GS, 1980) |
| "In the present study, we evaluated the effects of blockade of the RAS by the angiotensin-converting enzyme inhibitor enalapril and the angiotensin II receptor blocker losartan on left ventricular (LV) and right ventricular mass and LV dilation in relation to changes in central hemodynamics during the maintenance of minoxidil and aortocaval shunt-induced cardiac hypertrophy." | 3.69 | Effects of enalapril versus losartan on regression of volume overload-induced cardiac hypertrophy in rats. ( Leenen, FH; Ruzicka, M; Yuan, B, 1994) |
| "The antihypertensive and tissue-protective effects of nitrendipine were studied after long-term treatment of rats with experimental hypertension." | 3.68 | Long-term protective effects of nitrendipine in experimental hypertension. ( Kazda, S; Knorr, A; Neuser, D; Seuter, F; Stasch, JP, 1991) |
| "7 mm Hg by applying 1 mg/kg body weight minoxidil twice a day orally." | 3.67 | [Kidney function in spontaneously hypertensive rats under minoxidil treatment]. ( Hagemann, I; Kruse, I; Massow, S; Moritz, V; Pietsch, R; Scholze, J; Schürer, M; Siewert, H; Strangfeld, D; Su, LM, 1987) |
| "Five patients presenting with severe hypertension who failed to exhibit diastolic blood pressures less than 120 mm Hg following the oral administration of propranolol (60--80 mg) and furosemide (40 mg) received minoxidil (20 mg, p." | 3.66 | Rapid reduction of severe hypertension with minoxidil. ( Alpert, MA; Bauer, JH, 1980) |
| "The systemic, cardiovascular hemodynamic and biochemical interactions between clonidine and minoxidil were studied in ten patients with refractory and/or accelerated hypertension." | 3.66 | Cardiovascular hemodynamic interactions between clonidine and minoxidil in hypertensive patients. ( Angeli-Greaves, M; Hernandez-Pieretti, O; Morillo, J; Silva, H; Urbina-Quintana, A; Velasco, M, 1983) |
| "The hemodynamic response to minoxidil, an orally active, potent vasodilator, was evaluated in 11 patients with severe chronic congestive heart failure (CHF)." | 3.66 | Minoxidil therapy in chronic congestive heart failure: acute plus long-term hemodynamic and clinical study. ( Chatterjee, K; Holly, AN; McKay, CR; Parmley, WW; Ports, TA, 1982) |
| "We examined the hemodynamic interaction between clonidine, a centrally acting antiadrenergic drug, and minoxidil, a potent antihypertensive vasodilator in 10 inpatients with refractory or accelerated hypertension or both." | 3.66 | Systemic and cardiac hemodynamic interactions between clonidine and minoxidil. ( Aliendres, R; Andrews-Figueroa, P; Hernańdez-Pieretti, O; Morillo, J; Ramiŕez, A; Urbina-Quintana, A; Velasco, M, 1981) |
| "The efficacy and side effects of two potent vasodilatators, namely diazoxide and minoxidil given orally, were compared in 11 patients who had hypertension refractory to conventional drug treatment." | 3.66 | [Comparison of oral diazoxide and minoxidil in refractory hypertension]. ( Glück, Z; Grimm, M; Keusch, G; Meier, A; Minder, I; Reubi, FC; Weidmann, P, 1980) |
| "Eight patients with arteriosclerotic systolic hypertension whose blood pressure had been nonresponsive to conventional antihypertensive therapy, were given minoxidil in daily doses of 4 to 15 mg." | 3.66 | Hazards in treatment of systolic hypertension. ( Aygen, MM; Rosenfeld, JB; Traub, YM, 1979) |
| "The mechanism of minoxidil-induced cardiac hypertrophy and its consequences for the myocardium have not been determined." | 1.29 | Structural and functional consequences of minoxidil-induced cardiac hypertrophy. ( Cifani, JR; Khairallah, PA; Milovanovic, M; Moravec, CS; Ruhe, T, 1994) |
| "Minoxidil treatment for 8 weeks in both strains resulted in a decrease in mean arterial pressure and increases in ventricular weight to body weight ratios, plasma IR-ANP concentrations (in WKY from 133 +/- 20 to 281 +/- 34 pg ml-1, P less than 0." | 1.28 | Release of atrial natriuretic peptide from rat myocardium in vitro: effect of minoxidil-induced hypertrophy. ( Kinnunen, P; Leppäluoto, J; Ruskoaho, H; Taskinen, T, 1990) |
| "Treatment with hydralazine did not affect left ventricular weight and caused a small increase in the weight of the right ventricle." | 1.27 | Effects of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats. ( Leenen, FH; Tsoporis, J, 1988) |
| "Minoxidil is a potent antihypertensive vasodilator." | 1.27 | Minoxidil does not possess androgenic activity. ( Broulik, PD; Horký, K, 1988) |
| "Clonidine was given in doses of 0." | 1.26 | Clonidine and prazosin effects in hypernoradrenergic vasodilator-treated and beta-blocker-treated patients. ( Mitchell, HC; Pettinger, WA, 1981) |
| "Minoxidil treatment lowered blood pressure from 178/112 +/- 8/5 mm Hg (means +/- SEM) to 14/95 +/- 6/3 mm Hg." | 1.26 | Treatment of drug-resistant hypertension with minoxidil or angiotensin-converting enzyme inhibitor: blood pressure, renin, aldosterone, and electrolyte responses. ( Baer, L; Radichevich, I; Williams, GS, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (75.76) | 18.7374 |
| 1990's | 5 (15.15) | 18.2507 |
| 2000's | 1 (3.03) | 29.6817 |
| 2010's | 1 (3.03) | 24.3611 |
| 2020's | 1 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Sanabria, B | 1 |
| Vanzela, TN | 1 |
| Miot, HA | 1 |
| Müller Ramos, P | 1 |
| Coquand-Gandit, M | 1 |
| Jacob, MP | 1 |
| Fhayli, W | 1 |
| Romero, B | 1 |
| Georgieva, M | 1 |
| Bouillot, S | 1 |
| Estève, E | 1 |
| Andrieu, JP | 1 |
| Brasseur, S | 1 |
| Bouyon, S | 1 |
| Garcia-Honduvilla, N | 1 |
| Huber, P | 1 |
| Buján, J | 1 |
| Atanasova, M | 1 |
| Faury, G | 1 |
| Ong, SL | 1 |
| Zhang, Y | 1 |
| Sutton, M | 1 |
| Whitworth, JA | 1 |
| Mitchell, HC | 2 |
| Pettinger, WA | 2 |
| Javier, R | 1 |
| Dumler, F | 1 |
| Park, JH | 1 |
| Bok, DV | 1 |
| Riley, RW | 1 |
| Levin, NW | 1 |
| Bauer, JH | 2 |
| Alpert, MA | 1 |
| Baer, L | 1 |
| Radichevich, I | 1 |
| Williams, GS | 1 |
| Velasco, M | 2 |
| Silva, H | 1 |
| Morillo, J | 2 |
| Urbina-Quintana, A | 2 |
| Hernandez-Pieretti, O | 2 |
| Angeli-Greaves, M | 1 |
| Johnson, BF | 1 |
| Black, HR | 1 |
| Beckner, R | 1 |
| Weiner, B | 1 |
| Angeletti, F | 1 |
| Záruba, K | 1 |
| Rohacek, M | 1 |
| Grauer, W | 1 |
| McKay, CR | 1 |
| Chatterjee, K | 1 |
| Ports, TA | 1 |
| Holly, AN | 1 |
| Parmley, WW | 1 |
| Bianchetti, MG | 1 |
| Weidmann, P | 3 |
| Boehringer, K | 1 |
| Link, L | 1 |
| Schiffl, H | 1 |
| Beretta-Piccoli, C | 1 |
| Colombo, JP | 1 |
| Andrews-Figueroa, P | 1 |
| Ramiŕez, A | 1 |
| Aliendres, R | 1 |
| Meier, A | 1 |
| Glück, Z | 1 |
| Keusch, G | 1 |
| Grimm, M | 1 |
| Minder, I | 1 |
| Reubi, FC | 1 |
| Ruzicka, M | 1 |
| Yuan, B | 2 |
| Leenen, FH | 5 |
| Moravec, CS | 1 |
| Ruhe, T | 1 |
| Cifani, JR | 1 |
| Milovanovic, M | 1 |
| Khairallah, PA | 1 |
| Pedersen, OL | 1 |
| Keusch, GW | 1 |
| Campese, V | 1 |
| Lee, DB | 1 |
| Upham, AT | 1 |
| Massry, SG | 1 |
| Larochelle, P | 1 |
| Hamet, P | 1 |
| Beroniade, V | 1 |
| Kuchel, O | 1 |
| Traub, YM | 1 |
| Aygen, MM | 1 |
| Rosenfeld, JB | 1 |
| Ryan, JR | 1 |
| Jain, AK | 1 |
| McMahon, FG | 1 |
| Knorr, A | 1 |
| Kazda, S | 1 |
| Neuser, D | 1 |
| Stasch, JP | 1 |
| Seuter, F | 1 |
| Kinnunen, P | 1 |
| Taskinen, T | 1 |
| Leppäluoto, J | 2 |
| Ruskoaho, H | 2 |
| Fields, N | 1 |
| Tsoporis, J | 2 |
| Lee, HC | 1 |
| Redman, HC | 1 |
| Reams, GP | 1 |
| Fenje, P | 1 |
| Broulik, PD | 1 |
| Horký, K | 1 |
| Hagemann, I | 1 |
| Su, LM | 1 |
| Strangfeld, D | 1 |
| Pietsch, R | 1 |
| Kruse, I | 1 |
| Schürer, M | 1 |
| Siewert, H | 1 |
| Moritz, V | 1 |
| Massow, S | 1 |
| Scholze, J | 1 |
| Wendling, MG | 1 |
| DuCharme, DW | 1 |
1 review available for minoxidil and Body Weight
| Article | Year |
|---|---|
Minoxidil therapy in refractory hypertension analysis of 155 patients.
Topics: Adult; Animals; Body Weight; Drug Therapy, Combination; Female; Humans; Hypertension; Hypertrichosis | 1978 |
4 trials available for minoxidil and Body Weight
| Article | Year |
|---|---|
A comparison of minoxidil and hydralazine in non-azotemic hypertensives.
Topics: Adult; Blood Pressure; Body Weight; Female; Heart Rate; Humans; Hydralazine; Hypertension; Male; Mid | 1983 |
Minoxidil in severe hypertension.
Topics: Adult; Blood Pressure; Body Weight; Clinical Trials as Topic; Female; Heart Rate; Humans; Hypertensi | 1978 |
Minoxidil treatment of severe hypertension.
Topics: Adult; Blood Pressure; Blood Urea Nitrogen; Body Weight; Diuretics; Drug Therapy, Combination; Elect | 1975 |
Pseudo renal artery stenosis (PRAS) syndrome.
Topics: Angiography; Blood Pressure; Body Weight; Creatinine; Double-Blind Method; Enalapril; Humans; Hydral | 1989 |
28 other studies available for minoxidil and Body Weight
| Article | Year |
|---|---|
Adverse effects of low-dose oral minoxidil for androgenetic alopecia in 435 patients.
Topics: Adult; Alopecia; Body Weight; Dermatologic Agents; Headache; Humans; Hypertrichosis; Male; Minoxidil | 2021 |
Chronic Treatment with Minoxidil Induces Elastic Fiber Neosynthesis and Functional Improvement in the Aorta of Aged Mice.
Topics: Aging; Animals; Aorta; Biomechanical Phenomena; Blood Pressure; Body Weight; Collagen; Elastic Tissu | 2017 |
Hemodynamics of dexamethasone-induced hypertension in the rat.
Topics: Animals; Antihypertensive Agents; Body Fluids; Body Weight; Cardiac Output; Dexamethasone; Heart Rat | 2009 |
Clonidine and prazosin effects in hypernoradrenergic vasodilator-treated and beta-blocker-treated patients.
Topics: Adrenergic beta-Antagonists; Blood Pressure; Body Weight; Clonidine; Diastole; Diuretics; Female; Hu | 1981 |
Long-term treatment with minoxidil in patients with severe renal failure.
Topics: Acute Kidney Injury; Adult; Body Weight; Female; Furosemide; Humans; Hypertension; Hypertension, Pul | 1980 |
Rapid reduction of severe hypertension with minoxidil.
Topics: Adult; Blood Pressure; Body Weight; Dose-Response Relationship, Drug; Female; Furosemide; Hemodynami | 1980 |
Treatment of drug-resistant hypertension with minoxidil or angiotensin-converting enzyme inhibitor: blood pressure, renin, aldosterone, and electrolyte responses.
Topics: Adult; Aldosterone; Blood Pressure; Body Weight; Captopril; Creatinine; Drug Resistance; Female; Hum | 1980 |
Cardiovascular hemodynamic interactions between clonidine and minoxidil in hypertensive patients.
Topics: Adult; Blood Pressure; Body Weight; Clonidine; Dopamine beta-Hydroxylase; Drug Interactions; Heart R | 1983 |
[Fluid retention with pericardial effusion in minoxidil therapy (author's transl)].
Topics: Body Weight; Humans; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Minoxidil; Pericardia | 1982 |
Minoxidil therapy in chronic congestive heart failure: acute plus long-term hemodynamic and clinical study.
Topics: Adult; Aged; Body Weight; Cardiac Output; Diuretics; Female; Heart Failure; Hemodynamics; Humans; Ma | 1982 |
Comparative evaluation of the new vasodilator carprazidil and minoxidil in the treatment of moderate to severe hypertension.
Topics: Adult; Aged; Blood Pressure; Body Weight; Creatinine; Electrolytes; Female; Heart Rate; Hormones; Hu | 1982 |
Systemic and cardiac hemodynamic interactions between clonidine and minoxidil.
Topics: Adult; Blood Pressure; Body Weight; Clonidine; Female; Heart; Heart Rate; Hemodynamics; Humans; Hype | 1981 |
[Comparison of oral diazoxide and minoxidil in refractory hypertension].
Topics: Blood Glucose; Blood Pressure; Body Weight; Diazoxide; Diuretics; Drug Therapy, Combination; Electro | 1980 |
Effects of enalapril versus losartan on regression of volume overload-induced cardiac hypertrophy in rats.
Topics: Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Volume; Body Weight; Cardiomegaly; Coron | 1994 |
Structural and functional consequences of minoxidil-induced cardiac hypertrophy.
Topics: Animals; Body Weight; Cardiomegaly; Heart; Male; Minoxidil; Myocardial Contraction; Myocardium; Papi | 1994 |
[Treatment of severe hypertension with minoxidil combined with beta-blocking agents and diuretics].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Body Weight; Diuretics; Drug Therapy, Combination; Female; | 1975 |
Hazards in treatment of systolic hypertension.
Topics: Aged; Arteriosclerosis; Body Weight; Coronary Disease; Diuretics; Female; Follow-Up Studies; Humans; | 1979 |
Chronic arterial vasodilation, central hemodynamics, and cardiac hypertrophy in spontaneously hypertensive rats.
Topics: Animals; Arteries; Blood Pressure; Body Weight; Cardiac Output; Cardiomegaly; Drinking; Heart Rate; | 1992 |
Long-term protective effects of nitrendipine in experimental hypertension.
Topics: Animals; Arteriosclerosis; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Endothelins; Hydr | 1991 |
Release of atrial natriuretic peptide from rat myocardium in vitro: effect of minoxidil-induced hypertrophy.
Topics: Animals; Atrial Natriuretic Factor; Body Weight; Cardiomegaly; Hemodynamics; In Vitro Techniques; Ki | 1990 |
Differential effects of the calcium antagonist, nisoldipine, versus the arterial vasodilator, minoxidil, on ventricular anatomy, intravascular volume, and sympathetic activity in rats.
Topics: Animals; Blood Volume; Body Weight; Catecholamines; Drinking; Eating; Heart; In Vitro Techniques; Ma | 1989 |
The effect of triple drug therapy on renal function in patients with essential hypertension.
Topics: Adrenergic beta-Antagonists; Aged; Aldosterone; Antihypertensive Agents; Atenolol; Betaxolol; Blood | 1989 |
Effects of arterial vasodilators on cardiac hypertrophy and sympathetic activity in rats.
Topics: Animals; Blood Pressure; Blood Volume; Body Weight; Cardiomegaly; Epinephrine; Heart; Heart Rate; He | 1988 |
Immunoreactive atrial natriuretic peptide in ventricles, atria, hypothalamus, and plasma of genetically hypertensive rats.
Topics: Animals; Atrial Natriuretic Factor; Blood Pressure; Body Weight; Cardiomegaly; Heart Rate; Hypertens | 1988 |
Effects of minoxidil on blood pressure and cardiac hypertrophy in two-kidney, one-clip hypertensive rats.
Topics: Animals; Blood Pressure; Body Weight; Cardiomegaly; Drinking; Hypertension, Renal; Male; Minoxidil; | 1985 |
Minoxidil does not possess androgenic activity.
Topics: Androgens; Animals; Body Weight; Dihydrotestosterone; Male; Mice; Minoxidil; Orchiectomy; Organ Size | 1988 |
[Kidney function in spontaneously hypertensive rats under minoxidil treatment].
Topics: Animals; Blood Pressure; Body Weight; Diuresis; Electrolytes; Glomerular Filtration Rate; Heart Rate | 1987 |
Effects of chronic administration of prostaglandin E1 (PGE1) on arterial blood pressure of unanesthetized hypertensive rats.
Topics: Animals; Blood Pressure; Body Weight; Female; Hypertension; Hypertension, Renal; Kidney; Male; Minox | 1974 |